学会速報レポート

ESMO World Congress on Gastrointestinal Cancer 2019(WCGC2019)

海外学会などで発表されたホットでタイムリーな演題を専門医が厳選。レポートとコメントを掲載します。

2019年7月3日~6日にバルセロナで開催された ESMO World Congress on Gastrointestinal Cancer 2019より消化器癌の注目演題のレポートを掲載しています。

ESMO-GI FLASH REPORT - Abstract O-014 -

O-014:Trifluridine/tipiracil (FTD/TPI, TAS-102) with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer. A Danish investigator-initiated randomized study

ESMO-GI FLASH REPORT - Abstract LBA-003 -

Abstract LBA-003
A phase III study of TAS-118 plus Oxaliplatin versus S-1 plus Cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study). / Yoon-Koo Kang, et al.

ESMO-GI FLASH REPORT - Abstract SO-001 -

Abstract SO-001
Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as the second-line treatment in patients with advanced gastric cancer. / Shigenori Kadowaki, et al.

ESMO-GI FLASH REPORT - Abstract LBA-006 -

LBA-006 : BEACON CRC : A Randomised, 3-Arm, Phase-3 Study of Encorafenib and Cetuximab With or Without Binimetinib vs. Choice of Either Irinotecan or FOLFIRI plus Cetuximab in BRAF V600E-Mutant Metastatic Colorectal Cancer